Literature DB >> 6807224

Altered coagulation protein content after albumin resuscitation.

C E Lucas, A M Ledgerwood, E F Mammen.   

Abstract

Previous studies showed that the random addition of supplemental albumin to a resuscitation regimen of blood, salt, and frozen plasma caused a significant (p = less than 0.05) fall in fibrinogen clotting activity (FC) and a rise in prothrombin times (PT) in seriously injured patients; the partial thromboplastin times (PTT) were insignificantly prolonged. Based upon these findings, frozen plasma samples, prospectively collected in 41 non-albumin patients and 35 albumin patients, were analyzed immunologically, in duplicate, for protein content of coagulation factor VIII (VIIIAg), prothrombin (IIAg), fibrinogen (FAg), antithrombin III (ATAg), and fibrin(ogen) split products (FSP). Supplemental albumin resuscitation was associated with a significant fall in FAg (83 +/- 9 versus 124 +/- 10 SE mg/dl), VIIIAg (97 +/- 13 versus 127 +/- 135 SE %), IIAg (54 +/- 3 versus 80 +/- 4 SE %), and ATAg (14 +/- 0.8 +/- 19 +/- 0.8 SE mg%) with no significant changes in FSP. FSP, however, were more than 20 micrograms/ml in 13 of 41 nonalbumin patients versus four of 35 albumin patients (X2 = 4.5, p less than 0.05). Reduced coagulation activity following albumin supplementation seems partly caused by a decrease of coagulation protein content; increased fibrinolysis in the albumin patients is not the cause. Decreased coagulation protein content parallels the fall in coagulation activity and the need for postresuscitation blood transfusions. The role of reduced coagulation synthesis in these changes needs further study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807224      PMCID: PMC1352476          DOI: 10.1097/00000658-198208000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Proceedings: Postresuscitation hypertension. Etiology, morbidity, and treatment.

Authors:  A M Ledgerwood; C E Lucas
Journal:  Arch Surg       Date:  1974-04

2.  The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.

Authors:  M B Garvey; J M Black
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Clinical significance of altered coagulation tests after massive transfusion for trauma.

Authors:  C E Lucas; A M Ledgerwood
Journal:  Am Surg       Date:  1981-03       Impact factor: 0.688

5.  Altered coagulation after albumin supplements for treatment of oligemic shock.

Authors:  S D Johnson; C E Lucas; S J Gerrick; A M Ledgerwood; R F Higgins
Journal:  Arch Surg       Date:  1979-04
  5 in total
  6 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

Review 2.  Fluid resuscitation of hypovolemia.

Authors:  J A Sturm; D H Wisner
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

3.  Fresh frozen plasma supplement to massive red blood cell transfusion.

Authors:  D J Martin; C E Lucas; A M Ledgerwood; J Hoschner; M D McGonigal; D Grabow
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

4.  Effect of albumin resuscitation on canine coagulation activity and content.

Authors:  W C Leibold; C E Lucas; A M Ledgerwood; E F Mammen; R Denis; D Grabow; R J Staricco
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

5.  The effects of Hespan on serum and lymphatic albumin, globulin, and coagulant protein.

Authors:  C E Lucas; R Denis; A M Ledgerwood; D Grabow
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

6.  Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data.

Authors:  Manuel Burggraf; Arzu Payas; Max Daniel Kauther; Carsten Schoeneberg; Sven Lendemans
Journal:  World J Emerg Surg       Date:  2015-09-22       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.